Marc Scheineson comments on which Food and Drug Administration user fee policy riders have the greatest chance of being passed.
In the News
November 17, 2022
Bloomberg Law | FDA Lab Test Oversight at Risk of Getting Cut from Year-End Bill
Media Contact